Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive
Stem Cell & Regenerative Medicine

Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive

Dwi Wanna Jul 20, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have identified a biological pathway that could lead to…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption

Dwi Wanna Jul 13, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Develop Breakthrough Reversible Nonhormonal Male Contraceptive Method Targeting Meiosis

Dwi Wanna Jul 5, 2026 0

In a significant advancement for reproductive medicine, scientists at Cornell University have identified a viable pathway toward a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery at Weill Cornell Medicine Enhances Blood Stem Cell Regeneration and Bone Marrow Transplant Efficacy

Dwi Wanna Jul 4, 2026 0

The discovery of a singular molecular mechanism that governs the transition of blood stem cells from a dormant state to…

Read More
Stem Cell & Regenerative Medicine

Cornell Researchers Identify Breakthrough Nonhormonal Pathway for Reversible Male Contraception

Dwi Wanna Jun 28, 2026 0

The quest for a male contraceptive that is safe, effective, and entirely reversible has long been described by the medical…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception

Dwi Wanna Jun 21, 2026 0

In a breakthrough that could redefine the landscape of reproductive health, researchers at Cornell University have announced a significant advancement…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Breakthrough Nonhormonal Path Toward Reversible Long Acting Male Contraception.

Dwi Wanna Jun 13, 2026 0

In a landmark advancement for reproductive science, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis

Dwi Wanna Jun 6, 2026 0

In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic Interruption

Dwi Wanna Jun 5, 2026 0

In a significant advancement for reproductive medicine, researchers at Cornell University have successfully demonstrated a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna Jun 5, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More

Posts pagination

1 2 3
TWiV 1285: Encapsidating Viruses 2025Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key MarketsScience News: A Century of Empowering Public Understanding of ScienceBoosting one protein helps the brain fight Alzheimer’s
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ